EUTM file information

017872882

COHESMYO


March 11, 2018

Trademark Summary

The trademark application COHESMYO was filed by Genzyme Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 24, 2018, and it was registered by office on August 31, 2018 without any oppositions.

The application was filed in French (English was selected as the second language).

Change of name and address of the trademark registration was recorded on February 10, 2019. Change of name and professional address of the trademark registration was recorded on February 1, 2022. Change of name and address of the trademark registration was recorded on August 16, 2022.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system
    2. Pharmaceuticals for the treatment of cancer, thrombosis and respiratory diseases
    3. Pharmaceuticals for the treatment of lysosomal diseases
    4. Pharmaceuticals for the prevention and treatment of infectious diseases, namely viral and bacterial infections.